Handugan, Rosalina A.
HRN: 11-32-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CIPROFLOXACIN 500MG (TAB)
08/17/2022
08/21/2022
PO
500mg
BID
UTI (Resolving)
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes